Attovia Therapeutics, Inc. (ATTO) vs Design Therapeutics, Inc. (DSGN)
A side-by-side comparison of Attovia Therapeutics, Inc. and Design Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ATTO
Attovia Therapeutics, Inc.
$18.09HealthcareDelayed quote: Oct 6, 2026, 12:00 PM EDT
DSGN
Design Therapeutics, Inc.
$12.25HealthcareDelayed quote: Oct 6, 2026, 12:00 PM EDT
Total return — ATTO vs DSGN
growth of $100 · dividends reinvested · last 1yATTO -17.8% (-17.8%/yr)DSGN -5.9% (-5.9%/yr)DSGN compounded faster over this window
ATTO DSGN
ATTO vs DSGN: by the numbers
- •ATTO is the larger company ($778M vs $765M market cap).
- •Both run net losses; DSGN's is the smaller (0.00% vs -4490.89% net margin).
Metrics side by side
Valuation
| Metric | ATTO | DSGN |
|---|---|---|
| P/B ratio | N/A | 3.79 |
Profitability
| Metric | ATTO | DSGN |
|---|---|---|
| Gross margin | 40.44% | 0.00% |
| Operating margin | -4974.74% | 0.00% |
| Net margin | -4490.89% | 0.00% |
| ROE | -40.21% | -35.07% |
| ROIC | -42.83% | -38.92% |
Growth (annualized)
| Metric | ATTO | DSGN |
|---|---|---|
| Total return CAGR (5Y) | N/A | -3.82% |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.